SPAC17H9.08 Antibody

What is SPAC17H9.08 and why is it studied in research?

SPAC17H9.08 is an uncharacterized mitochondrial carrier protein in Schizosaccharomyces pombe (fission yeast) that functions as a predicted mitochondrial coenzyme A transporter . This protein is of research interest primarily because of its role in cellular metabolism and mitochondrial function. Studying SPAC17H9.08 can provide insights into fundamental cellular processes including energy metabolism, mitochondrial transport mechanisms, and evolutionary conservation of carrier proteins across species. The protein's role in coenzyme A transport makes it particularly valuable for understanding how essential cofactors are shuttled within cellular compartments, which is crucial for numerous metabolic pathways .

What detection methods are compatible with SPAC17H9.08 antibodies?

SPAC17H9.08 antibodies have been validated for several detection methods, with ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) being the primary applications . For Western Blot applications, researchers should ensure proper protein extraction from S. pombe cells, with particular attention to mitochondrial fraction isolation when focusing specifically on the native localization of the protein. The antibody shows good specificity when used with appropriate blocking solutions to minimize background. Immunohistochemistry and immunofluorescence methods may also be applicable, though these may require additional optimization steps compared to the standard applications .

How should SPAC17H9.08 antibodies be stored to maintain reactivity?

Proper storage of SPAC17H9.08 antibodies is crucial for maintaining their reactivity and specificity. The recommended storage conditions include avoiding repeated freeze-thaw cycles by using a manual defrost freezer . For long-term storage, keeping the antibody at -20°C to -70°C will maintain its activity for approximately 12 months from the date of receipt . After reconstitution, the antibody can be stored at 2-8°C under sterile conditions for up to 1 month, or at -20°C to -70°C for up to 6 months . For working solutions, aliquoting the antibody and storing at 4°C can prevent protein degradation that occurs with repeated freezing and thawing. Addition of carrier proteins like BSA (0.1-1%) or glycerol (20-50%) can further enhance stability during storage, particularly for diluted working solutions.

How can SPAC17H9.08 antibodies be used to investigate mitochondrial coenzyme A transport mechanisms?

Investigating mitochondrial coenzyme A transport mechanisms using SPAC17H9.08 antibodies requires sophisticated experimental approaches. A recommended methodology involves combining immunoprecipitation with metabolic flux analysis. Researchers can isolate intact mitochondria from S. pombe, then use SPAC17H9.08 antibodies to perform co-immunoprecipitation experiments to identify protein interaction partners . This approach can be complemented with isotope-labeled coenzyme A to track transport kinetics in wild-type versus SPAC17H9.08-depleted mitochondria.

For more detailed mechanistic studies, researchers can employ reconstitution assays where purified SPAC17H9.08 is incorporated into liposomes, followed by transport assays with fluorescently labeled coenzyme A derivatives. The specificity of transport can be verified using competitive inhibition assays with known mitochondrial carrier inhibitors. Western blot analysis using the SPAC17H9.08 antibody can confirm the presence of the protein in these reconstituted systems .

What are the best approaches for using SPAC17H9.08 antibodies in comparative studies across yeast species?

When conducting comparative studies across yeast species using SPAC17H9.08 antibodies, researchers should first assess cross-reactivity with homologous proteins in target species. Sequence alignment analysis of mitochondrial coenzyme A transporters across Saccharomyces cerevisiae, Schizosaccharomyces pombe, and other yeast species can identify conserved epitope regions that may be recognized by the antibody .

A robust methodology involves:

• Preparing standardized protein extracts from multiple yeast species under identical conditions

• Performing Western blot analysis with carefully controlled protein loading

• Using appropriate housekeeping protein controls specific to each species

• Quantifying relative expression levels using densitometry

For species where cross-reactivity is weak, epitope mapping can identify the specific regions recognized by the antibody. This information can be used to design synthetic peptides for competitive binding assays, which can help determine if the antibody is indeed recognizing the true homolog in divergent species .

How can SPAC17H9.08 antibodies be integrated with proteomics approaches?

Integrating SPAC17H9.08 antibodies with proteomics approaches provides powerful insights into mitochondrial carrier protein complexes and their dynamic regulation. An advanced experimental workflow would involve antibody-based enrichment followed by mass spectrometry analysis. Specifically, immunoprecipitation using SPAC17H9.08 antibodies can isolate the protein along with its interacting partners . The precipitated proteins can then be analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify the components of the protein complex.

For quantitative proteomics studies, stable isotope labeling with amino acids in cell culture (SILAC) can be employed in S. pombe cells under different conditions (e.g., normal versus metabolic stress). After labeling, mitochondrial fractions can be isolated, and SPAC17H9.08 antibodies can be used for immunoprecipitation followed by LC-MS/MS analysis. This approach allows for quantitative comparison of protein interactions under different physiological conditions .

Additional advanced applications include:

• Proximity-dependent biotin identification (BioID) where SPAC17H9.08 is fused to a biotin ligase, followed by streptavidin pulldown and antibody verification

• Chemical crosslinking combined with immunoprecipitation to capture transient protein interactions

• Super-resolution microscopy using fluorescently labeled SPAC17H9.08 antibodies to visualize the spatial distribution within mitochondria at nanometer resolution

What are effective strategies for optimizing Western blot protocols with SPAC17H9.08 antibodies?

Optimizing Western blot protocols for SPAC17H9.08 antibodies requires careful attention to several critical parameters. To achieve high-quality results, researchers should implement the following methodological refinements:

• Sample preparation: For mitochondrial proteins like SPAC17H9.08, enrichment of the mitochondrial fraction is recommended. Use a gentle lysis buffer (250 mM sucrose, 20 mM HEPES-KOH pH 7.4, 10 mM KCl, 1.5 mM MgCl₂, 1 mM EDTA, 1 mM EGTA) with protease inhibitors, followed by differential centrifugation to isolate mitochondria .

• Protein denaturation: Complete denaturation is crucial for exposing all epitopes. Use Laemmli buffer with 5% β-mercaptoethanol and heat samples at 95°C for 5 minutes. For membrane proteins like mitochondrial carriers, extending heating time to 10 minutes may improve denaturation .

• Gel percentage optimization: Use 10-12% polyacrylamide gels for optimal separation of SPAC17H9.08 (expected molecular weight range).

• Transfer conditions: Semi-dry transfer at 15V for 30 minutes or wet transfer at 30V overnight at 4°C can improve transfer efficiency of mitochondrial membrane proteins.

• Blocking optimization: Test different blocking agents (5% non-fat dry milk, 3-5% BSA) in TBS-T to determine which provides the lowest background with SPAC17H9.08 antibodies .

• Antibody dilution optimization: Test a range of primary antibody dilutions (1:500 to 1:2000) to determine optimal signal-to-noise ratio .

How can researchers validate the specificity of SPAC17H9.08 antibodies?

Validating antibody specificity is crucial for ensuring reliable experimental results. For SPAC17H9.08 antibodies, a comprehensive validation strategy should include multiple complementary approaches:

• Genetic knockout controls: Generate S. pombe strains with SPAC17H9.08 gene deletion or knockdown (using RNAi or CRISPR systems). Western blot comparison between wild-type and knockout samples should show absence or significant reduction of the specific band in knockout samples .

• Epitope blocking experiments: Pre-incubate the antibody with excess purified antigen or immunizing peptide before use in Western blot or immunostaining. This should completely abolish specific signals if the antibody is truly specific .

• Recombinant protein controls: Express tagged recombinant SPAC17H9.08 (with His, GST, or FLAG tags) in heterologous systems like E. coli or insect cells. Perform parallel detection with both anti-tag antibodies and SPAC17H9.08 antibodies to confirm recognition of the same protein .

• Multiple antibody validation: Use multiple antibodies raised against different epitopes of SPAC17H9.08 and confirm they detect the same protein band at the expected molecular weight.

• Mass spectrometry validation: Perform immunoprecipitation with the SPAC17H9.08 antibody, followed by mass spectrometry analysis to confirm the identity of the precipitated protein .

• Cross-reactivity assessment: Test the antibody against closely related mitochondrial carrier proteins to ensure it doesn't cross-react with homologous proteins.

What methodological approaches can address inconsistent SPAC17H9.08 antibody performance across experiments?

Inconsistent antibody performance is a common challenge in research. For SPAC17H9.08 antibodies, several methodological approaches can help ensure consistent results across experiments:

• Antibody aliquoting and storage: Upon receipt, immediately aliquot the antibody into single-use volumes and store at -80°C. Avoid repeated freeze-thaw cycles which can significantly degrade antibody performance .

• Lot-to-lot validation: When receiving a new lot of SPAC17H9.08 antibody, perform side-by-side comparison with the previous lot using identical samples and protocols. Document optimal dilution factors for each lot.

• Sample preparation standardization: Develop standardized protocols for cell lysis and protein extraction. For membrane proteins like SPAC17H9.08, consistent solubilization conditions are particularly critical. Consider using digitonin or mild detergents to maintain native protein conformation .

• Internal controls: Include purified recombinant SPAC17H9.08 protein (even at low concentrations) as a positive control in each experiment to verify antibody performance.

• Standardized blocking and washing: Variations in blocking efficiency and washing stringency often contribute to inconsistent results. Use automated washing systems when possible and standardize blocking reagents (lot and concentration) .

• Data normalization strategy: Implement consistent normalization approaches using housekeeping proteins appropriate for mitochondrial studies (e.g., VDAC or cytochrome c oxidase subunits rather than cytosolic markers like GAPDH).

• Environmental factors control: Maintain consistent temperature and incubation times across experiments, as antibody-antigen binding kinetics are temperature-dependent.